Conference Coverage (NCVDG)

Data Trickle in from NIH AIDS Vaccine Trials Network

Published in AIDS Weekly, June 9th, 1997

Intriguing data are already trickling in from a cohort of U.S. men and women at high risk of HIV infection.

Created to conduct advanced tests of candidate AIDS vaccines, the HIV Vaccine Efficacy Trials Network (HIVNET) has now enrolled 4,892 high-risk, HIV negative subjects at its eight domestic sites.

The study, funded by the National Institutes of Health, has already yielded one major finding: a large-scale trial of an HIV vaccine is possible in the U.S., according to Connie Celum of the University of Washington, Seattle HIVNET site.

Celum and colleague Haynes Sheppard of the California Department of Health Services (DHS),...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry